Beta-lactamase-producing bacteria (BLPB) can play an important role in polymicrobial infections. They can have a direct pathogenic impact in causing the infection as well as an indirect effect through their ability to produce the enzyme beta-lactamase. BLPB may not only survive penicillin therapy but can also, as was demonstrated in in vitro and in vivo studies, protect other penicillin-susceptible bacteria from penicillin by releasing the free enzyme into their environment. This phenomenon occurs in upper respiratory tract, skin, soft tissue, surgical and other infections. The clinical, in vitro and in vivo evidence supporting the role of these organisms in the increased failure rate of penicillin in eradication of these infections and the implication of that increased rate on the management of infections is discussed© 2009 Brook; licensee BioMed Central Ltd.
CITATION STYLE
Brook, I. (2009, December 14). The role of beta-lactamase-producing-bacteria in mixed infections. BMC Infectious Diseases. https://doi.org/10.1186/1471-2334-9-202
Mendeley helps you to discover research relevant for your work.